What are the Entresto Alternatives?

Entresto alternatives depend on why you need a substitute, because the best option for one person may be a poor fit for another. In heart failure, the main alternatives are usually ARBs or ACE inhibitors, with other evidence-based medicines added to complete guideline-directed therapy.

Entresto Alternatives

Entresto is the brand name for sacubitril/valsartan, a combination medicine used mainly for heart failure with reduced ejection fraction. It lowers strain on the heart by affecting two hormone systems that control blood vessel tightening and salt retention.

When you look for alternatives, you are usually trying to solve one of four problems: Entresto is too expensive, unavailable, causing side effects, or not appropriate because of a medical reason such as angioedema, low blood pressure, kidney issues, or another contraindication.

The right substitute depends on whether you need a like-for-like replacement in the same drug class or a broader heart failure regimen that works well without Entresto.

What Entresto does

Entresto is not just a blood pressure pill. It is a heart failure medicine designed to reduce hospitalization and improve outcomes in people with symptomatic heart failure, especially HFrEF.

Its valsartan component blocks the angiotensin II receptor, while sacubitril increases natriuretic peptides, which help the body excrete salt and relax blood vessels. That dual action is why clinicians often prefer it when it is tolerated and accessible.

Because it is a specialized therapy, the phrase “Entresto alternative” can mean two different things. It can mean a direct substitute for the same treatment goal, or it can mean another medication plan that still treats heart failure effectively.

Best direct substitutes

If you cannot take Entresto, the most common direct substitutes are an ARB or an ACE inhibitor. These medicines act on the renin-angiotensin system and have a long track record in heart failure.

ARBs are often the first choice when Entresto cannot be used, especially if you want a medicine that avoids the cough commonly associated with ACE inhibitors. Common examples include valsartan and candesartan.

ACE inhibitors are another major option, especially enalapril and lisinopril. They are widely used, proven, and often cheaper than Entresto.

ARBs

ARBs are among the most practical Entresto alternatives because they target the same general pathway as the valsartan part of Entresto. They are usually favored when you need a substitute but still want disease-modifying heart failure therapy.

Frequently used ARBs include:

• Valsartan.
• Candesartan.

ARBs are especially useful if you have had ACE inhibitor cough or cannot tolerate ACE inhibitors for other reasons. They are also a common option when Entresto is stopped because it is not appropriate or not available.

ACE inhibitors

ACE inhibitors remain a cornerstone of heart failure treatment and are a standard fallback when Entresto is not an option. Common choices include enalapril and lisinopril.

They are often attractive because they are familiar, broadly available, and usually lower cost than Entresto. Enalapril has especially strong historical evidence in heart failure management.

The main drawback is tolerability. ACE inhibitors can cause cough, and in some people they can trigger angioedema, which makes them unsafe.

When Entresto is not appropriate

You should not assume every heart failure patient can simply switch to another medicine without review. The best alternative depends on the reason Entresto is being avoided.

Common reasons include:

• Prior angioedema.
• Symptomatic hypotension.
• Kidney dysfunction or rising creatinine.
• Hyperkalemia.
• Inability to afford the medication or fill the prescription.

If the issue is cough from an ACE inhibitor, an ARB is often the preferred replacement. If the issue is ARB or ACE inhibitor intolerance, a different class-based strategy may be needed.

If the issue is cost, you may be able to use a lower-cost ACE inhibitor or ARB while still following modern heart failure treatment principles.

Heart failure regimens without Entresto

The most important point is this: you usually do not replace Entresto with only one medicine. You replace it with a treatment plan.

Modern heart failure care often uses several evidence-based drug classes together. That approach can still be effective even when Entresto is unavailable or unsuitable.

The commonly cited foundational classes are:

• An ACE inhibitor or ARB.
• A beta-blocker such as carvedilol, metoprolol succinate, or bisoprolol.
• A mineralocorticoid receptor antagonist, such as spironolactone or eplerenone.
• An SGLT2 inhibitor such as dapagliflozin or empagliflozin.

This matters because a person who cannot use Entresto may still receive strong guideline-based benefit from the rest of the regimen.

Other important medicines

If you are comparing alternatives, you should also know about the medications that are often used alongside or instead of Entresto in selected patients.

Beta-blockers are central in heart failure because they slow the heart, reduce workload, and improve outcomes over time. The commonly used evidence-based choices are carvedilol, metoprolol succinate, and bisoprolol.

Mineralocorticoid receptor antagonists, especially spironolactone and eplerenone, can reduce hospitalizations and improve outcomes in appropriate patients. They are not a direct substitute for Entresto, but they are part of the same overall treatment strategy.

SGLT2 inhibitors are now a foundational part of heart failure treatment and are often used whether or not a patient takes Entresto. They provide benefit even though they were first known as diabetes medicines.

Hydralazine and isosorbide dinitrate

If you cannot take either an ACE inhibitor or an ARB, the combination of hydralazine and isosorbide dinitrate is a recognized alternative in selected heart failure patients.

This combination is especially important when renin-angiotensin system blockers are not tolerated or are contraindicated. It may also be particularly useful in certain patients with persistent symptoms despite other treatment.

The tradeoff is that it can be harder to tolerate because of headaches, dizziness, and multiple daily doses. Even so, it remains a meaningful option when Entresto and its closest substitutes are not usable.

Ivabradine and add-ons

Ivabradine is not a direct Entresto replacement, but it can be useful in specific patients with heart failure who remain in sinus rhythm and still have an elevated heart rate despite beta-blocker therapy. It is a targeted add-on rather than a primary substitute.

This is important because many people search for “Entresto alternatives” when what they really need is additional heart failure control. In that setting, the answer may be a combination of medicines, not just one replacement.

You should think of ivabradine as a second-line tool for heart rate control, not as a replacement for disease-modifying therapy.

Cost and access

For many people, the most practical reason to look for Entresto alternatives is price. Entresto is often more expensive than older heart failure medicines, so people sometimes need a lower-cost substitute.

In that case, ACE inhibitors and ARBs are usually the first medicines to discuss because they can be more affordable while still offering meaningful benefit. That is one reason many clinicians still rely on enalapril, lisinopril, valsartan, or candesartan.

If access is the issue rather than medical intolerance, the conversation is often about finding the most effective affordable regimen, not simply the closest brand-to-brand replacement.

Safety points

You should not mix Entresto with an ACE inhibitor, because that combination can raise the risk of angioedema. If you switch between an ACE inhibitor and Entresto, a washout period is required in clinical practice.

You should also be careful with blood pressure, kidney function, and potassium when using heart failure medicines that affect the renin-angiotensin system. These drugs can be highly beneficial, but they need monitoring.

If you already have kidney impairment or low blood pressure, the “best” alternative may be the one you can tolerate safely at the lowest effective dose.

How to choose

If you need a simple decision path, this is the usual logic:

1. If you need a close substitute for Entresto, start by looking at an ARB.
2. If an ARB is not suitable, an ACE inhibitor is the next common option.
3. If neither ACE inhibitors nor ARBs can be used, hydralazine/isosorbide dinitrate becomes important.
4. In every case, optimize the rest of heart failure therapy with a beta-blocker, an MRA, and an SGLT2 inhibitor when appropriate.

That sequence reflects both practical prescribing and current heart failure management logic. It also helps prevent the common mistake of treating Entresto as if it were the only effective heart failure medicine.

Special situations

If you have had angioedema, your alternative choices narrow quickly, and the prescriber may avoid both ACE inhibitors and Entresto depending on the history. In that case, an ARB or hydralazine/isosorbide dinitrate may be considered based on the full clinical picture.

If you mainly need a cheaper option, ACE inhibitors or ARBs are usually the most relevant alternatives. If you mainly need a medication because of side effects, the right switch depends on the exact side effect and your other conditions.

If you have symptoms despite treatment, the issue may not be “which Entresto alternative,” but whether your full heart failure regimen is complete.

What to ask about

When you discuss alternatives, you should ask about:

• Which substitute fits your heart failure type and severity.
• Whether ARB or ACE inhibitor is safer for your history.
• What monitoring you need for kidney function, potassium, and blood pressure.
• Whether you should also be on a beta-blocker, MRA, or SGLT2 inhibitor.
• Whether a lower-cost medicine could meet the same treatment goal.

These questions help you get a real treatment plan instead of a simple medication swap.

Key takeaway

The most common Entresto alternatives are ARBs and ACE inhibitors, with hydralazine/isosorbide dinitrate used when those options are not suitable. In modern heart failure care, the best result often comes from combining the right substitute with the rest of the foundational therapies rather than looking for one perfect replacement.

If you are choosing between Entresto alternatives for cost, tolerability, or access, the usual starting point is an ARB or ACE inhibitor, then a broader heart failure regimen built around beta-blockers, MRAs, and SGLT2 inhibitors as appropriate.